menu
    • menu

    Company profile for BrainsWay

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain four FDA-cleared indications backed by pivotal studies demonstrating clinically proven e...
    BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain four FDA-cleared indications backed by pivotal studies demonstrating clinically proven efficacy. Current indications include major depressive disorder, obsessive-compulsive disorder, smoking addiction, and anxious depression.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BrainsWayUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1 Van de Graaff Drive Burlington, MA 01803
    Telephone
    Telephone
    844-386-7001
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.brainsway.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/brainsway/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BrainsWay Invests $6M In NeuroLief After FDA MDD Nod
    BrainsWay Invests $6M In NeuroLief After FDA MDD Nod

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3262880/17676/en/BrainsWay-Completes-Additional-6-Million-Milestone-Based-Investment-in-Neurolief-Ltd-Following-FDA-Approval-of-Proliv-Rx-System-for-MDD.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share
    Brainsway Invests In Axis Integrated Mental Health For Revenue
    Brainsway Invests In Axis Integrated Mental Health For Revenue

    19 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/19/3258882/17676/en/BrainsWay-Completes-Revenue-Based-Milestone-Investment-into-Axis-Integrated-Mental-Health.html

    GLOBENEWSWIRE
    19 Mar 2026
    Share Share
    Brainsway Reports 2025 Q4 And Full-Year Financials & Operations
    Brainsway Reports 2025 Q4 And Full-Year Financials & Operations

    11 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/11/3253665/17676/en/BrainsWay-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Operational-Highlights.html

    GLOBENEWSWIRE
    11 Mar 2026
    Share Share
    BrainsWay To Release 2025 Financial Results On March 11, 2026
    BrainsWay To Release 2025 Financial Results On March 11, 2026

    25 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/25/3244525/17676/en/BrainsWay-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-March-11-2026.html

    GLOBENEWSWIRE
    25 Feb 2026
    Share Share
    Brainsway To Join Citi 2026 Medtech & Life Sciences Access Day
    Brainsway To Join Citi 2026 Medtech & Life Sciences Access Day

    23 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/23/3242562/17676/en/BrainsWay-to-Participate-in-the-Citi-2026-Unplugged-MedTech-and-Life-Sciences-Access-Day.html

    GLOBENEWSWIRE
    23 Feb 2026
    Share Share
    Brainsway Invests In Canadian Provider Brainstim Health Inc
    Brainsway Invests In Canadian Provider Brainstim Health Inc

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/19/3240982/17676/en/BrainsWay-Announces-New-Minority-Stake-Investment-in-Canadian-Provider-BrainStim-Health-Inc.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search